Internal Medicine, Hematology & Oncology · Jacksonville, FL
NPI
1679881502
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1301 Palm Ave Ste 700
Jacksonville, FL, 32207
Phone (904) 202-7300
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
516 services
Medicare patients, 2024
254
Average age 73
Drug cost, 2024
$2.4M
1,024 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dayra C Avila Lima was code 99214 (office e&m - established), 382 times for 214 patients. In total Dayra C Avila Lima billed 516 services in 8 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 382 | 214 | $92.10 | $35K |
| 99205 Office E&M - New | Office | 58 | 58 | $159.80 | $9,269 |
| 99215 Office E&M - Established | Office | 48 | 33 | $137.26 | $6,589 |
| 99213 Office E&M - Established | Office | 15 | 15 | $65.54 | $983 |
By year: 2022 $43K for 570 services; 2023 $46K for 511 services; 2024 $53K for 516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dayra C Avila Lima prescribed most often to Medicare patients was Letrozole, with 327 prescriptions and refills. In total Dayra C Avila Lima wrote 1,024 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 327 | 889 | 132 | $8,110 |
| Anastrozole Generic | 182 | 490 | 76 | $3,621 |
| Ibrance Palbociclib | 59 | 59 | Under 11 | $973K |
| Alendronate Sodium Generic | 45 | 125 | 23 | $306 |
| Tamoxifen Citrate Generic | 32 | 92 | 16 | $994 |
| Ondansetron Hcl Generic | 30 | 32 | 24 | $239 |
| Exemestane Generic | 28 | 52 | 12 | $6,177 |
| Prochlorperazine Maleate Generic | 28 | 28 | 22 | $365 |
| Truqap Capivasertib | 26 | 26 | Under 11 | $424K |
| Gabapentin Generic | 24 | 37 | 13 | $325 |
| Kisqali Ribociclib Succinate | 18 | 18 | Under 11 | $266K |
| Verzenio Abemaciclib | 18 | 18 | Under 11 | $242K |
| Kisqali Femara Co-Pack Ribociclib Succinate/Letrozole | 17 | 17 | Under 11 | $237K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 15 | 15 | Under 11 | $149 |
| Dexamethasone Generic | 14 | 14 | Under 11 | $277 |
Brand drugs: 194 claims; generic drugs: 830 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dayra C Avila Lima $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.